Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having ...

Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype ...

From delayed diagnoses to unequal pain treatment, racial bias in medicine can shape care in ways clinicians may not even ...

Latin America continues to lag the global decline in HIV-related mortality, prompting experts to identify research priorities ...

The FDA has approved belzutifan (Welireg, Merck) in combination with pembrolizumab (Keytruda, Merck) or the subcutaneous ...

Intermittent theta-burst stimulation matches the efficacy of standard transcranial magnetic stimulation for depression in ...

Patients place high value on listening, trust, and clear communication, which are factors that shape adherence, satisfaction, ...

Exosomes emerge as a potential alternative to stem cells in regenerative medicine, and early studies suggest roles in skin ...

Prepregnancy insulin resistance is associated with impaired fertility and increased pregnancy complications such as ...

Autologous hematopoietic stem cell transplant at experienced centers in the current era can include indefinite disease ...